ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,996.66
1.00%
US Tech 100
20,877.20
1.72%
다우존스 지수
43,487.83
0.78%
Bitcoin
107,230.44
3.99%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Marinus Pharmaceuticals Inc (MRNS)

  7. Marinus Pharmaceuticals Inc (MRNS) 뉴스

MRNS

Marinus Pharmaceuticals (MRNS)

Marinus Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:MRNS
일자시간출처헤드라인심볼기업
2025/01/0906:41Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:MRNSMarinus Pharmaceuticals Inc
2025/01/0809:15Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:MRNSMarinus Pharmaceuticals Inc
2025/01/0305:25Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:MRNSMarinus Pharmaceuticals Inc
2025/01/0305:25Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/12/3021:11Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/12/3021:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/12/3021:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/12/3021:00Business WireImmedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.NASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/12/2406:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/12/1106:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/12/1105:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/11/1522:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/11/1508:39Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/11/1505:04Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/11/1502:24Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/11/1423:34Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/11/1306:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/11/1306:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/11/1306:00Business WireMarinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial ResultsNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/11/0209:30Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/11/0209:30Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/11/0209:30Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/10/2421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/10/2421:00Business WireMarinus Pharmaceuticals Announces Topline Results From Phase 3 TrustTSC Trial of Oral Ganaxolone in Tuberous Sclerosis Complex and Commences Process to Explore Strategic AlternativesNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/10/1720:00Business WireMarinus Pharmaceuticals Presents Clinical Data From Pivotal Phase 3 RAISE Trial in Refractory Status Epilepticus at the Neurocritical Care Society 2024 Annual MeetingNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/10/1605:00Business WireMarinus Pharmaceuticals Further Strengthens Intellectual Property Estate with Method of Treatment Patent for ZTALMY® Titration RegimensNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/10/0920:00Business WireMarinus Pharmaceuticals Announces Podium and Poster Presentations at the Neurocritical Care Society 2024 Annual MeetingNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/10/0905:04Business WireMarinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/10/0220:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/09/2021:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:MRNS

최근 히스토리

COIN
GRTGBP
Graph Token
BOV
ETHE11
Hashdex Ethereum
TG
A283FK
Syngenta Finance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유